Goldman Sachs has increased its price target for First Hawaiian (FHB) from $25 to $26. Despite this adjustment in valuation, the firm maintains a Sell rating for the bank's shares. The revised outlook accounts for changes in expectations regarding margin and capital return.\n\nThe investment bank has also updated its earnings per share (EPS) forecasts for the years 2025, 2026, and 2027. These projections have been adjusted to $2.05, $2.10, and $2.15 respectively, up from the previous estimates of $1.95, $2.05, and $2.15. These revisions reflect updated views on fees and operating expenses for First Hawaiian (FHB, Financial).\n\nBased on the one-year price targets offered by 6 analysts, the average target price for First Hawaiian Inc (FHB, Financial) is $25.83 with a high estimate of $28.00 and a low estimate of $24.00. The average target implies an upside of 2.94% from the current price of $25.10. More detailed estimate data can be found on the First Hawaiian Inc (FHB) Forecast page.\n\nBased on the consensus recommendation from 8 brokerage firms, First Hawaiian Inc's (FHB, Financial) average brokerage recommendation is currently 3.6, indicating \"Underperform\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.\n\nBased on GuruFocus estimates, the estimated GF Value for First Hawaiian Inc (FHB, Financial) in one year is $26.06, suggesting a upside of 3.85% from the current price of $25.095. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the First Hawaiian Inc (FHB) Summary page.

Goldman Sachs Adjusts Price Target for First Hawaiian (FHB)

Goldman Sachs has raised its price target for First Hawaiian (FHB) from $25 to $26 while maintaining a Sell rating. The firm updated EPS forecasts for 2025–2027 to $2.05, $2.10, and $2.15, reflecting revised views on fees and expenses. Analysts' average one-year target price is $25.83, with a 2.94% upside from the current $25.10 share price. The average brokerage recommendation is 3.6, indicating 'Underperform' status.